Matches in Wikidata for { <http://www.wikidata.org/entity/Q92272187> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q92272187 description "clinical trial" @default.
- Q92272187 description "ensayo clínico" @default.
- Q92272187 description "ensayu clínicu" @default.
- Q92272187 description "klinisch onderzoek" @default.
- Q92272187 description "клінічне випробування" @default.
- Q92272187 description "临床试验" @default.
- Q92272187 name "Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68)" @default.
- Q92272187 name "Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68" @default.
- Q92272187 type Item @default.
- Q92272187 label "Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68)" @default.
- Q92272187 label "Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68" @default.
- Q92272187 prefLabel "Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68)" @default.
- Q92272187 prefLabel "Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68" @default.
- Q92272187 P1050 Q92272187-2972A305-4A5B-4E98-B85F-887B225E0D06 @default.
- Q92272187 P1050 Q92272187-6BB797CB-C282-454E-8D19-FC350AB8B44E @default.
- Q92272187 P1132 Q92272187-3F50D017-02A2-45D8-928A-79572B281E4D @default.
- Q92272187 P1476 Q92272187-1EFB784D-F600-4C0D-B168-188F827D47D8 @default.
- Q92272187 P17 Q92272187-6566D69D-B2ED-471F-83CA-869A9058879C @default.
- Q92272187 P2899 Q92272187-5ECFE7F4-ACE0-4E34-A4E9-64133E3978AD @default.
- Q92272187 P3098 Q92272187-75364C6E-1A2B-47C3-B13E-3A9EA044B0F4 @default.
- Q92272187 P31 Q92272187-C5404227-4831-4F18-926E-D48824BB9620 @default.
- Q92272187 P4844 Q92272187-51B1CD24-9D3B-4955-A257-27DB55221D3B @default.
- Q92272187 P580 Q92272187-C75D36FB-8C3F-4368-BD52-1792CF21EDC9 @default.
- Q92272187 P582 Q92272187-E7853DFB-AF70-4F0D-A63A-9F53055DB851 @default.
- Q92272187 P6099 Q92272187-BEB01489-F041-44D0-8AF9-0113E998E41C @default.
- Q92272187 P767 Q92272187-DC2AB7D9-7144-4925-9A93-FD81376A2DF7 @default.
- Q92272187 P8005 Q92272187-E19AA813-B7D5-44FC-A2D9-2647C27F09AC @default.
- Q92272187 P8363 Q92272187-4C2B1956-8993-476F-A668-7911C5EC4692 @default.
- Q92272187 P1050 Q12152 @default.
- Q92272187 P1050 Q181754 @default.
- Q92272187 P1132 "+2400" @default.
- Q92272187 P1476 "A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Trial to Evaluate the Effect of In-Hospital Initiation of Dapagliflozin on Clinical Outcomes in Patients With Heart Failure With Reduced Ejection Fraction Who Have Been Stabilized During Hospitalization for Acute Heart Failure DAPAgliflozin and Effect on Cardiovascular Events in ACuTe Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68)" @default.
- Q92272187 P17 Q30 @default.
- Q92272187 P2899 "+18" @default.
- Q92272187 P3098 "NCT04363697" @default.
- Q92272187 P31 Q30612 @default.
- Q92272187 P4844 Q216935 @default.
- Q92272187 P580 "2020-06-15T00:00:00Z" @default.
- Q92272187 P582 "2022-07-31T00:00:00Z" @default.
- Q92272187 P6099 Q42825046 @default.
- Q92272187 P767 Q731938 @default.
- Q92272187 P8005 Q76649614 @default.
- Q92272187 P8363 Q78089383 @default.